Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 161   

Articles published

AZN 5,435.00 +35.00 (0.65%)
price chart
Analyst at Goldman Sachs Keeps The AstraZeneca PLC (LON:AZN) Sell Rating They ...
Among 31 analysts covering AstraZeneca PLC (LON:AZN), 15 have Buy rating, 3 Sell and 13 Hold. Therefore 48% are positive. AstraZeneca PLC has GBX 7600 highest and GBX 3700 lowest target. GBX 5008.79's average target is -6.81% below currents ...
Breaking: AstraZeneca PLC (LON:AZN) “Buy” Rating Maintained by Analysts at ...  Weekly Register
For AstraZeneca, Cancer Drug Weighs on Go-It-Alone Stand -- WSJ
LONDON - AstraZeneca PLC Chief Executive Pascal Soriot made a promise to investors three years ago as the Anglo-Swedish drug maker was fending off takeover advances from Pfizer Inc.: If left alone, AstraZeneca would nearly double its revenue within a ...
AstraZeneca plc 4.5% Potential Upside Indicated by Liberum Capital
AstraZeneca plc with EPIC/TICKER (LON:AZN) had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Liberum Capital.
Liberum Capital downgrades European pharma sector to 'neutral', but ...  Proactive Investors UK
The Sage Group plc to Issue Dividend of GBX 5.22 (SGE)  Normangee Star
AstraZeneca PLC (AZN) Stock Will Show Resistance At $35.04
With all other things going on, AstraZeneca PLC (NYSE:AZN) has been on a run - rising 12.59 percent in just three months. It looks like traders are happy with the stock.
Financial Highlights of: AstraZeneca PLC (AZN)
AstraZeneca PLC (AZN) jumped 0.23 percent and ended the day at $34.72. The Average Volume of the company is 4.1 Million and P/E (price to earnings) ratio is 25.93, while Forward P/E ratio is 17.6.
Shore Capital Reconfirms The “Hold” Rating They've had for AstraZeneca PLC ...
Among 31 analysts covering AstraZeneca PLC (LON:AZN), 15 have Buy rating, 3 Sell and 13 Hold. Therefore 48% are positive. AstraZeneca PLC has GBX 7600 highest and GBX 3700 lowest target. GBX 5008.79's average target is -6.81% below currents ...
5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017
New Drugs Going Strong: AstraZeneca's newly launched drugs are contributing to its top line, thereby easing the impact of genericization on legacy products.
Form 6-K ASTRAZENECA PLC For: Jun 06
AstraZeneca PLC announces that, on 5 June 2017, it priced a three tranche Global bond offering totalling $2bn. The offering is expected to close on 12 June 2017, subject to customary closing conditions.
Mckinley Capital Management Raised By $921861 Its Astrazeneca Plc (AZN) Stake ...
Among 26 analysts covering International Consolidated Airlines Group (LON:IAG), 20 have Buy rating, 1 Sell and 5 Hold. Therefore 77% are positive.
Active Runner in Focus: AstraZeneca PLC (ZEG.DE)
Shares of AstraZeneca PLC (ZEG.DE) is moving on volatility today -1.70% or -1.06 rom the open. The XETRA listed company saw a recent bid of 61.43 on 876 volume.